The Effect of Antidopaminergic Medications on Changes in Clinical Measures of Huntington’s Disease Function, Cognition, Motor Signs, and Progression (P10-5.030)
To assess ADM impact on measures of HD progression over two years, we performed a causal inference analysis using data from the ENROLL-HD dataset.
Authors
- Kelly S. Chen (ORCID: https://orcid.org/0000-0003-1473-864X)
- Jeffrey D. Long (ORCID: https://orcid.org/0000-0001-7181-9652)
- Randal Hand
- Michael R. Hayden (ORCID: https://orcid.org/0000-0001-5159-1419)
- Michal Geva (ORCID: https://orcid.org/0000-0002-6949-0963)
- Paul Goldberg (ORCID: https://orcid.org/0000-0003-1612-7519)
Institutions
- University of Iowa (US)
- University of British Columbia (CA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211890
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00